BIOREGENX, INC. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-16.3% -$75K
$386K
Cost of Revenue↓-51.5% -$71K
$67K
Gross Profit↓-1.2% -$4K
$319K
R&D
$32K
SG&A↓-70.5% -$1M
$552K
D&A↓-97.6% -$2M
$52K
Operating Income↑+97.4% +$319K
$-8K
EBITDA↓-97.6% -$2M
$52K
Interest Expense↑+2111.2% +$78K
$82K
Other Income/Expense
$2M
Pretax Income
$-705K
Tax Provision
$0
Net Income↑+79.6% +$314K
$-81K
Gross Margin↑+12.6pts
82.7%
Operating Margin↑+53.2pts
-1.7%
Net Margin↑+50.4pts
-15.9%
Effective Tax Rate
0.0%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+0.0pts
-4.4%
Operating Lease Cost↑+0.0% +$0
$5K
Revenue YoY Variation↑+15.8pts
-16.3%
Income YoY Variation↑+10.7pts
97.4%
Revenue QoQ Variation↓-1.3pts
-24.0%
Income QoQ Variation↑+23.6pts
92.1%